Fast Titration Of Quetiapine Versus Currently Approved Titration
NCT00254813 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2011-01-26
Summary
The purpose of this study is to evaluate the safety and tolerability of a more rapid dose titration in acute schizophrenic patients compared to the conventional titration.
Conditions
- Psychotic Disorders
Interventions
- DRUG
-
Quetiapine
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
AstraZeneca Norway Medical Director, MD · AstraZeneca
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-10-31
- Completion
- 2005-09-30
Countries
- Norway
Study Locations
More Related Trials
-
Quetiapine XR in Schizophrenic Patients
NCT01071135 ·Status: TERMINATED ·Phase: PHASE3
-
A Comparison of Seroquel vs. Risperidone in Schizophrenia
NCT00034905 ·Status: COMPLETED ·Phase: PHASE4
-
High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder
NCT00297947 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Quetiapine on Negative Symptoms and Cognition
NCT00305422 ·Status: COMPLETED ·Phase: PHASE3
-
Non-interventional (NI) Study to Observe Efficacy and Usage of Quetiapine in Acute Episodes of Schizophrenia and as Maintenance Therapy Following Standard Clinical Practice in Croatia
NCT00981123 ·Status: COMPLETED
-
Quetiapine Treatment for Post-Traumatic Stress Disorder (PTSD)
NCT00237393 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder.
NCT00521365 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Quetiapine for the Treatment of Mood Disorders in Adolescents
NCT00221468 ·Status: COMPLETED ·Phase: PHASE3
-
An Open Label, Double-blind Discontinuation Study of Quetiapine Extended Release(XR)
NCT00606541 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Adherence in Adolescents and Children Treated on Quetiapine
NCT00680888 ·Status: COMPLETED
-
Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder
NCT00156715 ·Status: COMPLETED ·Phase: PHASE4
-
Seroquel® Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With Schizophrenia
NCT00255515 ·Status: COMPLETED ·Phase: PHASE4
-
The Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic Patients
NCT00295412 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Quetiapine in Generalised Social Anxiety Disorder
NCT00302770 ·Status: TERMINATED ·Phase: PHASE3
-
Addition of Quetiapine in Obsessive Compulsive Disorder - Westenberg Study
NCT00318539 ·Status: COMPLETED ·Phase: PHASE2
-
Seroquel Long-Term NIS for Schizophrenia Patients
NCT00523783 ·Status: COMPLETED
-
Use of Quetiapine as an Add on Therapy in the Treatment of Post Traumatic Stress Disorder
NCT00306540 ·Status: COMPLETED ·Phase: PHASE3
-
Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study
NCT01689389 ·Status: COMPLETED
-
Quetiapine in the Treatment of Psychotic Depression - a Pilot Study
NCT00751504 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine in Postpartum Depression
NCT00681668 ·Status: TERMINATED ·Phase: PHASE2
-
Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone
NCT00600756 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum Disorders
NCT00252226 ·Status: COMPLETED ·Phase: PHASE3
-
Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect
NCT00534222 ·Status: COMPLETED
-
Seroquel STACK Study in Schizophrenic or Schizoaffective Subjects
NCT00328978 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine XR Versus Sertraline in Acute Bipolar Depression as add-on Therapy
NCT00857584 ·Status: COMPLETED ·Phase: PHASE3